Business Overview
Sintetica B2B/B2C.
Dual distribution model
Direct sales to hospitals: distribution in Switzerland, Germany, Austria, and in the United States.
Sales through partners: license agreements with top-tier partners in 50+ countries.
Sintetica is a fast-growing speciality pharma company fully integrated from R&D and production to distribution.
Breakdown by Geography
2023
RoW | 14%
Switzerland | 31%
Germany & Austria | 24%
US | 31%
RoW breakdown
2023
Outside EU | 43%
EU | 57%
Breakdown by Channel
2023
B2B | 45%
B2C | 55%
Breakdown by Therapeutic Area
2023
Neuromodulation | 11%
Emergency & Intensive care | 53%
Anaesthesia | 17%
Analgesics and other | 19%